Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...

1 Department of Medical and Health Sciences, Division of Cardiovascular Medicine, Linköping University Hospital, Linköping, Sweden 2 Department of Cardiology, Uppsala University Hospital, Uppsala, ...

Background There is substantial interest in the cardiovascular effects of e-cigarette use, highlighting the need to update ...

St George's Hospital Medical School, Histopathology Department, London, UK Professor M J Davies, St George's Hospital Medical School, Histopathology Department, Cranmer Terrace, London SW17 0RE, UK If ...

Correspondence to: Dr Siew Yen Ho, Paediatrics, Faculty of Medicine, National Heart & Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, UK; yen.ho{at}ic.ac.uk According to Walmsley, ...

Background Patients with cryptogenic stroke or embolic stroke of undetermined source (ESUS) face a high risk of recurrent ischaemic stroke, but the optimal antithrombotic strategy remains unclear.

Objective Coronary artery bypass grafting (CABG) is an established revascularisation strategy for multivessel and left main coronary artery disease. Although aspirin is routinely recommended for ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Background Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier ...

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and systemic embolism after LVT, and many aspects of its management still exist in a ...